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ABSTRACT
A Disintegrin And Metalloprotease (ADAM) 10 exerts essential roles during organ 
development and tissue integrity in different organs, mainly through activation of 
the Notch pathway. However, only little is known about its implication in liver tissue 
physiology. 
Here we show that in contrast to its role in other tissues, ADAM10 is dispensable 
for the Notch2-dependent biliary tree formation. However, we demonstrate that 
expression of bile acid transporters is dependent on ADAM10. Consequently, mice 
deficient for Adam10 in hepatocytes, cholangiocytes and liver progenitor cells develop 
spontaneous hepatocyte necrosis and concomitant liver fibrosis. 
We furthermore observed a strongly augmented ductular reaction in 15-week 
old ADAM10Δhep/Δch mice and demonstrate that c-Met dependent liver progenitor cell 
activation is enhanced. Additionally, liver progenitor cells are primed to hepatocyte 
differentiation in the absence of ADAM10.
These findings show that ADAM10 is a novel central node controlling liver tissue 
homeostasis. 
Highlights:
Loss of ADAM10 in murine liver results in hepatocyte necrosis and concomitant 
liver fibrosis.
ADAM10 directly regulates expression of bile acid transporters but is dispensable 
for Notch2-dependent formation of the biliary system.
Activation of liver progenitor cells is enhanced through increased c-Met signalling, 
in the absence of ADAM10.




Proteolytic release of transmembrane ectodomains, 
also termed ectodomain shedding, is an irreversible post-
translational mechanism to regulate protein function. 
Members of the A Disintegrin and Metalloprotease 
(ADAM) family are major mediators of receptor shedding. 
The family member ADAM10 has been identified as major 
sheddase for Notch receptors [1], thereby enabling Notch 
signalling. Complete knockout of Adam10 in mice resulted 
in embryonic lethality phenocopying Notch1 knockout 
mice [1]. Conditional deletion of ADAM10 in intestinal 
[2] or haematopoietic [3] tissue clearly demonstrated its 
importance for progenitor cell-mediated tissue integrity. 
Strikingly, reduced progenitor cell proliferation in these 
mice was mainly linked to impaired Notch signalling [4]. 
In order to ensure tissue homeostasis under 
physiological stress conditions, the liver relies on its 
enormous regenerative capacity. Acute injury such as 
paracetamol poisoning or surgical removal of parts of the 
liver induce compensatory hypertrophy and proliferation 
of the remaining hepatocytes [5]. However, during 
chronic liver damage upon toxic insult or consistent 
viral load, hepatocyte proliferation is compromised due 
to replicative arrest. This leads to activation of stem 
cell-like liver progenitor cells (LPCs) that are capable 
of hepatocytic or cholangiocytic differentiation upon 
appropriate stimulation. After hepatocyte damage, 
phagocytosing macrophages secrete Wnt ligands which 
induce hepatocytic differentiation of LPCs. Biliary 
damage however, induces myofibroblasts to secrete Notch 
ligands in order to promote differentiation of LPCs into 
biliary epithelial cells [6]. The importance of the Notch 
pathway for liver development and liver regeneration 
has been further emphasised by mutations in the Notch 
ligand Jagged-1, as well as mutations in Notch2 [7] which 
have been found in patients with Alagille syndrome. 
These patients develop cholestatic liver diseases due to 
bile duct paucity. In mice, deficiency for Notch2 resulted 
in impaired development of intrahepatic bile ducts 
accompanied by foci of hepatocyte death [8, 9]. 
In this study, we generated mice deficient for 
Adam10 in α-fetoprotein (ALFP)-expressing bipotential 
hepatoblasts and consequently in adult LPCs, hepatocytes 
and cholangiocytes. Surprisingly, Notch2-dependent 
biliary tree formation was not impaired by the loss 
of ADAM10 activity. However, upon loss of hepatic 
ADAM10 we observed spontaneous hepatocyte necrosis 
due to downregulation of bile acid transporter expression, 
leading to a ductular reaction. We demonstrate that loss of 
ADAM10 in LPCs results in enhanced LPC proliferation 
by increased c-Met signalling, as well as in an augmented 
potential of LPCs to differentiate into hepatocytes. Taken 
together this study identifies ADAM10 as a central 
regulator of liver tissue homeostasis.
RESULTS
Hepatic deficiency of ADAM10 results in 
parenchymal liver damage and persistent liver 
fibrosis
ADAM10 is expressed in the liver and the extra-
hepatic biliary system throughout embryonic development 
[10]. In order to analyse its physiological role in the liver 
we used Alfp-Cre transgenic mice [11] to limit ADAM10 
deficiency to the liver. We confirmed exclusive Cre 
expression in adult hepatocytes and cholangiocytes by 
breeding Alfp-Cre mice to EYFP reporter mice (Figure 
S1A and S1B). 
ADAM10Δhep/Δch mice exhibited an efficient deletion 
of Adam10 (Figure S1C) in the liver and a significant 
reduction of ADAM10 expression levels (Figure 
S1D). ADAM10 expression was not affected in other 
tissues (Figure S1E). ADAM10Δhep/Δch mice were born 
at a mendelian ratio and normal vitality. ADAM10Δhep/
Δch mice were both generated on a pure C57BL/6 and a 
mixed 129/C57BL/6 background. Both mouse strains 
displayed a similar phenotype, supporting the notion 
that the observed phenotype developed due to a lack 
of ADAM10. We focused our analysis in the following 
mainly on ADAM10Δhep/Δch mice on a mixed 129/C57BL/6 
background as these mice developed the phenotype more 
rapidly.
Surprisingly, ADAM10Δhep/Δch animals displayed 
macroscopic signs of liver parenchyma damage in situ 
(Figure 1A) accompanied by increased liver-to-body 
weight ratios in 4-week old animals (Figure S2A and 
S2B). ADAM10Δhep/Δch mice revealed multiple foci 
of hepatocyte necrosis (Figure 1B and Figure S2C), 
predominantly located between the portal triad and 
the central vein (Figure 1B). Accordingly, we detected 
elevated serum levels of alanine transaminase (ALT) 
and alkaline phosphatase (ALP) in ADAM10Δhep/Δch mice 
(Figure 1C and Figure S2D). 
Hepatocyte damage was accompanied by a 
significant increase in hepatic stellate cell (HSC) 
activation, as evidenced by morphology (Figure S3A) and 
an increase of α smooth muscle actin (Acta2, αSMA) at 
the mRNA (Figure 1D) and the protein level (Figure 1E). 
Accordingly, we detected an upregulation of pro-fibrotic 
genes (Figure S3B-S3D) and liver fibrosis in 15-week 
old ADAM10Δhep/Δch mice (Figure 1F and 1G, Figure S3E 
and F).All ADAM10Δhep/Δch animals showed an increased 
spleen-to-body weight ratio (Figure S2B) which might 
be directly linked to liver fibrosis and a resulting portal 
hypertension.
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Figure 1: Mice with hepatic deficiency of ADAM10 develop spontaneous hepatocyte necrosis and concomitant liver 
fibrosis. A. Necrotic lesions are macroscopically visible on livers of ADAM10Δhep/Δch mice. White arrows indicate single necrotic lesions. 
B. H&E stainings of histological sections show necrotic areas predominantly in zone 2 of ADAM10-deficient livers. Necrotic areas are 
marked by asterisk. PV: portal vein; CV: central vein; Scale bars indicate 200 µm and in magnified areas 50 µm. C. ALT and ALP serum 
levels are upregulated in 4- and 15-week old ADAM10Δhep/Δch mice compared to the respective controls (n = 3-16 animals for each subgroup). 
D. Expression of the αSMA gene (Acta2) is increased in livers of ADAM10Δhep/Δch mice as assessed by qRT-PCR on mRNA from total liver 
tissue (n = 4-9 animals per subgroup). E. α-smooth muscle actin (αSMA) staining of histological liver sections reveals persistent activation 
of hepatic stellate cells in ADAM10-deficient livers. Scale bars indicate 200 µm. F. Sirius Red staining indicates increased liver fibrosis 
in ADAM10-deficient livers. Scale bars indicate 200 µm (n = 4-16 animals per subgroup). G. Quantification of hydroxyproline (n = 3-9 
animals per subgroup) content and analysis of Col1A1 expression (n = 4-9 animals per subgroup) in total liver extracts confirms increased 
liver fibrosis in ADAM10-deficient livers. Data represent the mean ± standard error of the mean. (* P < 0.005;** P < 0.01; ***P < 0.001).
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ADAM10 is dispensable for Notch-dependent 
biliary tree formation
Previous reports have shown that biliary tree 
formation depends on Notch2 activation [12]. Given the 
prominent role of ADAM10 in Notch activation in other 
tissues, hypothesised that hepatocyte necrosis was due 
to malformation of the biliary system. Surprisingly, we 
did neither detect alterations in the overall biliary tree 
structure as assessed by retrograde resin cast (Figure 
2A) nor abnormalities in the ultrastructural morphology 
of bile canaliculi (Figure S4A). In line with these 
findings, Notch2 cleavage and in vitro tube formation of 
the murine bipotential liver progenitor cell line BMOL 
[13] on matrigel, mimicking biliary tree formation, 
was not reduced by the ADAM10 inhibitor GI254023X 
nor ADAM10-specific siRNA (Figure 2B and 2C and 
Figure S4B). However, the γ-secretase inhibitor DAPT 
impeded Notch2 cleavage and tube formation on matrigel 
significantly (Figure 2B and 2C) as previously described 
[14]. We furthermore did not detect significant alterations 
in the expression of the Notch target genes Hes1 and Hey1 
(data not shown). These data demonstrate that Notch2-
dependent differentiation of hepatoblasts and LPCs 
into cholangiocytes is still functional in the absence of 
ADAM10.
ADAM10 regulates expression of hepatic bile acid 
transporters
Defects of bile acid transporters can cause 
hepatocyte death and are involved in the pathogenesis 
of several liver diseases including cholestasis, fatty liver 
disease and liver cancer [15]. We therefore determined 
expression of bile acid transporters in total liver extracts. 
We found a significant reduction in Abcb11, Slco1b2 and 
Abcc2 mRNA expression levels (Figure 2D). Accordingly, 
we detected partial loss of Mrp2, encoded by Abcc2 in 
liver tissue sections of ADAM10Δhep/Δch mice (Figure 
S4C). The expression levels of Abcc2/Mrp2 correlated 
significantly to the expression levels of Adam10, while 
ALT serum levels inversely correlated significantly 
to Adam10 expression levels (Figure S4D). Reduced 
expression of Abcc2 was directly linked to ADAM10 
deletion, since siRNA-mediated suppression of ADAM10 
in BMOL cells (Figure 2E), but not inhibition of ADAM10 
protease activity (Figure S4E), markedly reduced Abcc2 
gene expression. Deficiencies in Mrp2, BSEP and Oatp1b2 
in humans and mice result in increased serum levels of 
bilirubin [15]. Accordingly, we detected elevated serum 
levels of total bilirubin (Figure 2F) and total biliary acids 
in ADAM10Δhep/Δch mice (Figure 2G and Figure S4F). 
Hepatic loss of ADAM10 induces a ductular 
reaction
The area of liver damage was strongly reduced in 15-
week old ADAM10Δhep/Δch animals (Figure 3A), indicating 
an on-going regenerative process. We detected strong 
cell proliferation in liver tissue sections of ADAM10Δhep/
Δch mice, which was significantly increased compared to 
controls (Figure 3B). We detected Ki67+ nuclei in cells 
with hepatocytic morphology (Figure 3B, black arrows) 
but also in smaller epithelial cells, in particular in livers 
of 15-week old ADAM10Δhep/Δch mice (Figure 3B, red 
arrows). The number of Ki67+ cells decreased in 15-week 
old ADAM10Δhep/Δch animals but proliferation remained 
significantly upregulated compared to wildtype controls 
(Figure 3B). 
We hypothesised that a subpopulation of small 
Ki67+ cells might be LPCs. We therefore analysed liver 
tissue sections by utilising antibodies against cytokeratin 
19 (CK19) and pan-cytokeratin (CKpan) that stain biliary 
epithelial cells and LPCs. As expected, wildtype animals 
only showed CK19- and CKpan- positive staining in 
cholangiocytic cells in periportal regions. In 4-week old 
ADAM10Δhep/Δch mice CK19+ and CKpan+ cells exclusively 
localised to portal ducts and necrotic areas that also stain 
due to cytokeratin rearrangement. In contrast, we detected 
an increase of CK19+ ductular structures with occasional 
single CK19+ and CKpan+ LPCs in the parenchyma in 
15-week old ADAM10Δhep/Δch mice (Figure 3C and Figure 
S5A). Importantly, at the later time point a population of 
CKpan+ cells also stained positive for CD44, indicating 
the presence of migratory stem-cell like liver progenitor 
cells (Figure 3C, white arrows).
Macrophage mobilisation has been observed to 
precede LPC activation [16]. Macrophages have been 
suggested as major regulators of LPC activation by 
producing the LPC mitogen TWEAK [17]. Interestingly, 
while the total number of F4/80+ macrophages was not 
increased in ADAM10Δhep/Δch mice, F4/80+ macrophages 
underwent spatial reorganisation and accumulated around 
the ductular structures in ADAM10Δhep/Δch mice compared 
to controls, suggesting an ongoing activation of LPCs 
(Figure 3D). 
LPC activation is enhanced in the absence of 
ADAM10
Immunofluorescent staining revealed proliferating 
CKpan+Ki67+ LPCs in 15-week old ADAM10Δhep/Δch mice 
which were absent in 4-week old ADAM10Δhep/Δch animals 
and wildtype controls (Figure 4A). 
In accordance with previous reports [17] TWEAK 
(Tnfsf12) expression levels remained unchanged (Figure 
4B). Transcript levels of the TWEAK-receptor Fn14 
(Tnfrsf12a) were strongly upregulated in ADAM10Δhep/Δch 
Oncotarget17435www.impactjournals.com/oncotarget
Figure 2: ADAM10 regulates expression of bile acid transporters but is dispensable for Notch-dependent biliary tree 
formation. A. Resin casts of the biliary tree appear similar in 4-week old wildtype and ADAM10Δhep/Δch mice. Scale bars indicate 2000 
µm and in the magnified area 500 µm. B. Inhibition of ADAM10 does not affect tube formation of  BMOL cells cultured on Matrigel. 
Total tube length and tubular junctions are significantly reduced in the presence of the γ-secretase inhibitor DAPT, but not in the presence 
of the ADAM10-inhibitor GI254023X. One representative and the quantification of five independent experiments (n = 5) are shown. Scale 
bars indicate 1000 µm. C. Notch2 cleavage in BMOL cells is not impaired by GI254023X-mediated inhibition of ADAM10 but abrogated 
upon DAPT-mediated γ-secretase inhibition. FL = full length D. Expression of Abcb11, Slco1b2 and Abcc2 genes, encoding for the bile 
acid transporters BCEP, Oatp1b2 and Mrp2 respectively, is downregulated in ADAM10Δhep/Δch mice. (n = 4-5 animals for each subgroup). 
E. siRNA-mediated downregulation of ADAM10 in the murine LPC line BMOL results in transcriptional repression of the Abcc2 gene 
encoding for Mrp2. (n = 4-6) F. Serum levels of total bilirubin are elevated in ADAM10Δhep/Δch mice (n = 3 animals for each subgroup). G. 
Serum levels of total bile acids are elevated in ADAM10Δhep/Δch mice (n = 3-10 animals for each subgroup). Data shown represent mean ± 
standard error of the mean. (*P < 0.05; **P < 0.01; ***P < 0.001).
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Figure 3: Loss of ADAM10 induces liver progenitor cell-mediated regeneration in ADAM10Δhep/Δch animals. A. 
Quantification of necrotic areas from histological sections (n = 4-9 animals for each subgroup) of ADAM10-deficient livers of 4- and 
15-week old mice suggests a decrease of tissue damage over time. B. Increased proliferation in livers of ADAM10Δhep/Δch mice as assessed 
by Ki67 staining. Scale bars indicate 200 µm and in the magnified area 50 µm. Black arrows designate Ki67+ hepatocytes. Red arrows 
indicate Ki67+ cells with a potential LPC morphology (n = 3-15 animals per subgroup). C. Ductular reaction and accumulation of LPCs 
in ADAM10Δhep/Δch mice as marked by CKpan and CD44 staining of liver tissue sections of ADAM10Δhep/Δch mice. Images from 4-week old 
wildtype animals are representative for both age groups. Asterisk mark unspecific CKpan staining of necrotic hepatocytes. Arrows indicate 
CKpan+ CD44+ LPCs. Scale bars indicate 50 µm. D. Clustering of macrophages around LPCs in 4-week old ADAM10Δhep/Δch mice as marked 
by CKpan and F4/80 macrophage staining of liver tissue sections of ADAM10Δhep/Δch mice. Arrows indicate clusters of F4/80+ macrophages. 
Scale bars indicate 50 µm. Data represent the mean ± standard error of the mean. (**P < 0.01; ***P < 0.001).
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Figure 4: Activation of liver progenitor cells is enhanced in the absence of ADAM10 activity. A. Detection of proliferating 
LPCs in 15-week old ADAM10Δhep/Δch mice as assessed by CKpan/Ki67 immunofluorescent double staining. Arrows indicate CKpan+Ki67+ 
LPCs. Scale bars indicate 50 µm. B. Expression levels of Tnfsf12 coding for TWEAK are unaltered while the expression levels of Tnfrsf12a 
coding for Fn14 are increased in ADAM10Δhep/Δch mice (n = 4-5 animals per subgroup). C. Multiplex ELISA shows increased levels of 
the LPC mitogen HGF in the serum of ADAM10Δhep/Δch mice (n = 3-15 animals per subgroup). D. siRNA-mediated downregulation of 
ADAM10 in BMOL cells results in enhanced HGF-induced c-Met signalling, but not TWEAK-induced Fn14 signalling. Filled arrowhead 
indicates ADAM10 pro-form. Open arrowhead indicates ADAM10 mature form. One representative out of three independent experiments 
is shown. E. Differentiation of BMOL cells to hepatocytes is enhanced in the absence of ADAM10 as assessed by qPCR analysis of 
hepatocytic genes Alb and HNF4a and cholangiocytic genes HNF6 and HNF1b. F. Expression of HNF4α and the epithelial cell marker 
E-cadherin after differentiation is enhanced and expression of the cholangiocyte marker HNF1β is reduced in the absence of ADAM10 as 
assessed by immunoblotting. G. Immunofluorescent staining of siRNA-treated BMOL cells after differentiation reveals plasma membrane 
staining of E-cadherin, perinuclear staining of β-catenin and enhanced nuclear localisation of HNF4α in the absence of ADAM10. Data 
represent the mean ± standard error of the mean. (*P<0.005; **P<0.001; *** P<0.001).
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mice (Figure 4B), reflecting an increased number of LPCs 
in these animals. 
HGF is upregulated and essential in mouse models 
of LPC-mediated regeneration [16]. We found a significant 
increase in serum levels of HGF in ADAM10Δhep/Δch 
mice (Figure 4C). The receptor for HGF, c-Met, has 
been previously identified as a substrate of ADAM10-
mediated shedding [18]. Both, siRNA-mediated ADAM10 
suppression (Figure 4D) or pharmacological inhibition 
with GI254023X (Figure S5B) led to an enhanced c-Met 
and ERK1/2 phosphorylation in HGF-stimulated BMOL 
cells. We did not find a significant alteration of TWEAK 
signalling in BMOL cells in the absence of ADAM10, 
as evidenced by IκB degradation (Figure 4D and Figure 
S5B). These data indicate that enhanced pro-mitogenic-
signalling in LPCs in the absence of ADAM10 activity is 
mediated by HGF.
Hepatic differentiation of LPCs is enhanced in the 
absence of ADAM10
Previous reports have shown that during chronic 
liver damage LPCs can differentiate into hepatocytes [6]. 
As we observed ongoing regeneration in our ADAM10Δhep/
Δch mice, we adressed the potential of LPCs to differentiate 
into hepatocytes in the absence of ADAM10. We therefore 
subjected BMOL cells with siRNA-mediated ADAM10 
suppression to previously described differentiation 
conditions (Figure S5C) [13]. ADAM10 expression was 
upregulated during differentiation in both control and 
ADAM10 siRNA-treated BMOL cells. Interestingly, 
expression of the cholangiocytic markers HNF6 and 
HNF1β were reduced significantly more in ADAM10-
deficient BMOL cells on mRNA and protein level 
(Figure 4E-4G). Conversely, expression of the hepatocyte 
markers HNF4α and albumin, as well as the epithelial cell 
marker E-cadherin was markedly increased in ADAM10-
suppressed BMOL cells as compared to control cells 
(Figure 4E-4G). Nuclear localisation of HNF4α was 
enhanced in the absence of ADAM10 (Figure 4G). We 
did not detect enhanced nuclear localisation of β-catenin, 
indicating that Wnt signalling was not involved under 
the conditions of differentiation used (Figure 4G). These 
data show that the potential of LPCs to differentiate to 
hepatocytes is enhanced in the absence of ADAM10. 
DISCUSSION
A Disintegrin And Metalloprotease (ADAM) 10 
exerts essential roles during organ development and tissue 
integrity in many organs. In the present study we analysed 
its role in hepatocytes, cholangiocytes and liver progenitor 
cells using conditional Adam10-deficient mice.
In our study we found that ADAM10Δhep/Δch mice 
suffered from hepatocyte necrosis and concomitant liver 
fibrosis. Previous reports have shown that in the liver, 
biliary tree formation is dependent on Notch2 activation 
[12]. Notch activation upon ligand-binding involves two 
consecutive proteolytic events leading to the generation of 
Notch intracellular domain and subsequent transcriptional 
regulation of Notch-target genes. Previous reports have 
demonstrated that in most tissues studied so far ADAM10 
is responsible for the proteolytic cleavage of the Notch 
ectodomain [4].
Interestingly, ADAM10Δhep/Δch mice did not display 
abnormalities in bile duct architecture or bile canaliculi 
morphology. Furthermore, in vitro tubulogenesis was also 
independent of ADAM10. Our data suggest that Notch2-
dependent differentiation of hepatoblasts and bipotential 
liver progenitor cells into cholangiocytes is still functional 
in the absence of ADAM10 and is mediated by another 
protease. This is contrary to what has been observed 
before in other tissues, where loss of ADAM10 in the 
respective tissue stem cells impeded Notch-dependent 
stem cell activation [2, 3]. 
We observed down-regulation of the bile acid 
transporters Mrp2, BSEP, and Oatp1b2 in our mice and a 
concomitant increase in serum bilirubin, total bile acids, 
ALP and ALT. Deficiencies in Mrp2, BSEP and Oatp1b2 
are linked to hyperbilirubinemia and cholestasis [15, 19]. 
We therefore hypothesise that in our mice loss of bile 
acid transporters results in impaired secretion of bile 
acids leading to hepatocyte necrosis. Loss of Mrp2 was 
directly linked to ADAM10-deficiency as corroborated in 
vitro in the murine bipotential LPC line BMOL. Previous 
studies showed that the intracellular domain (ICD) of 
ADAM10 can translocate to the nucleus [20], suggesting 
that ADAM10 ICD contributes to transcriptional 
regulation. Interestingly, in our experiments inhibition 
of ADAM10 activity was not sufficient to downregulate 
Abcc2 expression in BMOL cells, suggesting that indeed 
ADAM10 ICD might be involved in the transcriptional 
regulation of Abcc2 and other bile acid transporters. 
Expansion of liver progenitor cells has been 
observed in a variety of human liver diseases such as 
chronical viral hepatitis, alcoholic liver disease and 
nonalcoholic fatty liver disease [21, 22]. Most likely 
as a consequence of persistent hepatocyte necrosis, 
ADAM10Δhep/Δch mice developed a ductular reaction with 
activation of the CKpan+ LPC compartment. Interestingly, 
LPC proliferation persisted in ADAM10Δhep/Δch mice at 
the later time point as marked by Ki67 staining despite 
a reduction in hepatic necrosis. We observed increased 
HGF signalling in the BMOL LPC line in the absence of 
ADAM10. ADAM10 therefore is an intrinsic negative 
regulator of LPC activation most likely through c-Met 
ectodomain shedding as reported to occur in other cell 
types [18].
Previous reports suggested that bipotential 
progenitors can emerge from adult hepatocytes through 
Wnt, Notch and TGF-β signalling [23-26]. At present 
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we cannot exclude the possibility that accumulation 
of LPCs in ADAM10Δhep/Δch mice is not only linked to 
enhanced LPC activation but may also be the result of de-
differentiation of hepatocytes. 
We furthermore found that LPCs had an increased 
potential to differentiate into hepatocytes in the absence 
of ADAM10. Under the differentiation conditions used 
we did not detect enhanced c-Met or Wnt signalling 
and the underlying molecular mechanism still has 
to be elucidaded. Interestingly, tissue inhibitor of 
metalloprotease 1 (TIMP-1), an inhibitor of ADAM10 
[27], is strongly upregulated in chronic liver disease and 
might enhance LPC differentiation to hepatocytes through 
ADAM10 inhibition. 
Taken together, we identified ADAM10 as a central 
node controlling liver tissue homeostasis based on three 
major findings: (I) ADAM10 or ADAM10-mediated 
signalling processes positively regulate expression of 
the bile acid transporters Mrp2, BSEP and Oatp1b2. 
(II) ADAM10 negatively regulates activation of liver 
progenitor cells through inactivation of c-Met signalling. 
(III) the potential of LPCs to differentiate into hepatocytes 
is augmented in the absence of ADAM10.
MATERIALS AND METHODS
Animal experimentation
To generate a hepatocyte- and cholangiocyte-
specific knockout of ADAM10, homozygously floxed 
mice (ADAM10fl/fl, [1]) were crossed with Alfp-Cre 
transgenic mice (B6.Tg(Alb1-cre)7Gsc, [11]) and their 
offspring who carry homozygously floxed ADAM10 and 
are positive for Alfp-Cre were termed ADAM10Δhep/Δch. For 
additional information see Supplementary Experimental 
Procedures.
Determination of alanine transaminase, alkaline 
phosphatase and bilirubin levels
Liver damage was assessed by measurement of 
ALT and ALP enzymatic activity and bilirubin levels in 
peripheral blood serum, according to the manufacturer’s 
instructions (Reflotron® Plus; Roche, Penzberg, Germany).
Bile duct plastination
Plastination of the biliary tree was performed 
as described previously [9]. Casts were imaged using 
an AZ100 microscope with a DS-Fi2 camera (Nikon, 
Düsseldorf, Germany).
Histological analysis and molecular techniques
See Supplementary Experimental Procedures
Cell culture, treatments and functional studies
See Supplementary Experimental Procedures
Statistics
Data were expressed as mean ± standard error of the 
mean. Comparisons between two groups were performed 
by applying the Student’s t test. If data were not normally 
distributed or if they had unequal variances, the Mann-
Whitney U test was employed for comparison of two 
groups. Measurement of the strength of the association 
between expressed genes or analytes was determined 
using Pearson product-moment correlation. All analyses 
were conducted using SigmaPlot 12.0 Software (Systat 
Software). A p value of < 0.05 was considered statistically 
significant. 
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